Search research articles
Contact Us
Filters
Showing results (371-380 of 394) with videos related to
Page
of 40
Sort By:
The Journal of Surgical Research
|
May 13, 2022
Frequency and Characteristics of Social Media Use among General Surgery Trainees
Hataka R Minami, Xujia Li, Samantha K Ong, et al.
Advanced Healthcare Materials
|
February 21, 2026
Kinetics of De Novo Bone and Bone Marrow Niche Formation With Hybrid Click Cryogels
Sangmin Lee, Kwasi Adu-Berchie, Azeem Sanjay Sharda, et al.
Obesity Surgery
|
February 17, 2024
A Prospective Multicenter Standard of Care Study of Outpatient Laparoscopic Sleeve Gastrectomy
Amit Surve, Daniel Cottam, Aurora Pryor, et al.
European Journal of Histochemistry : EJH
|
March 5, 2021
Immunopositivity for Siglec-15 in gastric cancer and its association with clinical and pathological parameters
Michael Williams Leal Quirino, Michelly Cristiny Pereira, Maria de Fátima Deodato de Souza, et al.
Disease Markers
|
December 13, 2019
Overexpression of UDP-Glucose 4-Epimerase Is Associated with Differentiation Grade of Gastric Cancer
Maria de Fátima Deodato de Souza, Antônio Felix da Silva Filho, Amanda Pinheiro de Barros Albuquerque, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
September 18, 2002
(-)-(9S)-9-(3-Bromo-4-fluorophenyl)-2,3,5,6,7,9-hexahydrothieno[3,2-b]quinolin-8(4H)-one 1,1-dioxide (A-278637): a novel ATP-sensitive potassium channel opener efficacious in suppressing urinary bladder contractions. I. In vitro characterization
Murali Gopalakrishnan, Steven A Buckner, Kristi L Whiteaker, et al.
Science (New York, N.Y.)
|
September 7, 2023
Fast and destructive density currents created by ocean-entering volcanic eruptions
Michael A Clare, Isobel A Yeo, Sally Watson, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 3, 2011
4-Quinazolinyloxy-diaryl ureas as novel BRAFV600E inhibitors
Mark W Holladay, Brian T Campbell, Martin W Rowbottom, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 17, 2002
A-317491, a novel potent and selective non-nucleotide antagonist of P2X3 and P2X2/3 receptors, reduces chronic inflammatory and neuropathic pain in the rat
Michael F Jarvis, Edward C Burgard, Steve McGaraughty, et al.
International Journal of Pharmaceutics
|
March 11, 2014
An in vivo evaluation of amphiphilic, biodegradable peptide copolymers as siRNA delivery agents
Stephanie E Barrett, Marc T Abrams, Rob Burke, et al.
Page
of 40
Search research articles
Search
Showing results (371-380 of 394) with videos related to
Sort By:
Page
of 40
The Journal of Surgical Research
|
May 13, 2022
Frequency and Characteristics of Social Media Use among General Surgery Trainees
Hataka R Minami, Xujia Li, Samantha K Ong, et al.
Advanced Healthcare Materials
|
February 21, 2026
Kinetics of De Novo Bone and Bone Marrow Niche Formation With Hybrid Click Cryogels
Sangmin Lee, Kwasi Adu-Berchie, Azeem Sanjay Sharda, et al.
Obesity Surgery
|
February 17, 2024
A Prospective Multicenter Standard of Care Study of Outpatient Laparoscopic Sleeve Gastrectomy
Amit Surve, Daniel Cottam, Aurora Pryor, et al.
European Journal of Histochemistry : EJH
|
March 5, 2021
Immunopositivity for Siglec-15 in gastric cancer and its association with clinical and pathological parameters
Michael Williams Leal Quirino, Michelly Cristiny Pereira, Maria de Fátima Deodato de Souza, et al.
Disease Markers
|
December 13, 2019
Overexpression of UDP-Glucose 4-Epimerase Is Associated with Differentiation Grade of Gastric Cancer
Maria de Fátima Deodato de Souza, Antônio Felix da Silva Filho, Amanda Pinheiro de Barros Albuquerque, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
September 18, 2002
(-)-(9S)-9-(3-Bromo-4-fluorophenyl)-2,3,5,6,7,9-hexahydrothieno[3,2-b]quinolin-8(4H)-one 1,1-dioxide (A-278637): a novel ATP-sensitive potassium channel opener efficacious in suppressing urinary bladder contractions. I. In vitro characterization
Murali Gopalakrishnan, Steven A Buckner, Kristi L Whiteaker, et al.
Science (New York, N.Y.)
|
September 7, 2023
Fast and destructive density currents created by ocean-entering volcanic eruptions
Michael A Clare, Isobel A Yeo, Sally Watson, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 3, 2011
4-Quinazolinyloxy-diaryl ureas as novel BRAFV600E inhibitors
Mark W Holladay, Brian T Campbell, Martin W Rowbottom, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 17, 2002
A-317491, a novel potent and selective non-nucleotide antagonist of P2X3 and P2X2/3 receptors, reduces chronic inflammatory and neuropathic pain in the rat
Michael F Jarvis, Edward C Burgard, Steve McGaraughty, et al.
International Journal of Pharmaceutics
|
March 11, 2014
An in vivo evaluation of amphiphilic, biodegradable peptide copolymers as siRNA delivery agents
Stephanie E Barrett, Marc T Abrams, Rob Burke, et al.
Page
of 40